ReShape Lifesciences, Inc. Forecast, price target & analysts
ReShape Lifesciences, Inc. Target price 2025 - Analyst rating & recommendation
ReShape Lifesciences, Inc. Classifications & Recommendation:
ReShape Lifesciences, Inc. Price Target
| Target Price | $1,450.00 |
| Price | $3.11 |
| Potential |
46,523.80%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a ReShape Lifesciences, Inc. price target 2026.
The average ReShape Lifesciences, Inc. target price is $1,450.00.
This is
46,523.80%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend ReShape Lifesciences, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ReShape Lifesciences, Inc. stock has an average upside potential 2026 of
46,523.80%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 8.01 | 11.99 |
| 7.72% | 49.73% | |
| Net Margin | -89.01% | -10.36% |
| 32.17% | 88.36% |
1 Analyst has issued a sales forecast ReShape Lifesciences, Inc. 2025 . The average ReShape Lifesciences, Inc. sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $8.0m | 7.72% |
|---|---|---|
| 2025 |
$12.0m
49.73%
Unlock
|
|
1 Analyst has issued a net profit forecast ReShape Lifesciences, Inc. 2025 . The average ReShape Lifesciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-7.1m | 37.40% |
|---|---|---|
| 2025 |
$-1.2m
82.61%
Unlock
|
|
Net Margin
| 2024 | -89.01% | 32.17% |
|---|---|---|
| 2025 |
-10.36%
88.36%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -345.78 | -0.36 |
| 87.52% | 99.90% | |
| P/E | negative | |
| EV/Sales | 0.26 |
1 Analysts have issued a ReShape Lifesciences, Inc. forecast for earnings per share. The average ReShape Lifesciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-345.78 | 87.52% |
|---|---|---|
| 2025 |
$-0.36
99.90%
Unlock
|
|
P/E ratio
| Current | -0.07 | 99.42% |
|---|---|---|
| 2025 |
-0.52
644.99%
Unlock
|
|
Based on analysts' sales estimates for 2025, the ReShape Lifesciences, Inc. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 0.68 | 94.29% |
|---|---|---|
| 2025 |
0.26
61.37%
Unlock
|
|
P/S ratio
| Current | 1.03 | 63.32% |
|---|---|---|
| 2025 |
0.37
64.42%
Unlock
|
|
ReShape Lifesciences, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
